Cargando…

IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3

Although the effects of growth hormone (GH) therapy on spinocerebellar ataxia type 3 (SCA3) have been examined in transgenic SCA3 mice, it still poses a nonnegligible risk of cancer when used for a long term. This study investigated the efficacy of IGF-1, a downstream mediator of GH, in vivo for SCA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yong-Shiou, Cheng, Wen-Ling, Chang, Jui-Chih, Lin, Ta-Tsung, Chao, Yi-Chun, Liu, Chin-San
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962315/ https://www.ncbi.nlm.nih.gov/pubmed/35203722 http://dx.doi.org/10.3390/biomedicines10020505

Ejemplares similares

In Vitro Efficacy and Molecular Mechanism of Curcumin Analog in Pathological Regulation of Spinocerebellar Ataxia Type 3
por: Wu, Yu-Ling, et al.
Publicado: (2022)

Coenzyme Q10 Supplementation Increases Removal of the ATXN3 Polyglutamine Repeat, Reducing Cerebellar Degeneration and Improving Motor Dysfunction in Murine Spinocerebellar Ataxia Type 3
por: Wu, Yu-Ling, et al.
Publicado: (2022)

Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induced Neurotoxicity in Cell and Drosophila Models of Spinocerebellar Ataxia Type3
por: Wu, Yu-Ling, et al.
Publicado: (2017)

Spinocerebellar ataxia type 36 in the Han Chinese
por: Lee, Yi-Chung, et al.
Publicado: (2016)

Transcriptomic and Metabolic Network Analysis of Metabolic Reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice
por: Lin, Yu-Te, et al.
Publicado: (2021)

Event-Related Desynchronization/Synchronization in Spinocerebellar Ataxia Type 3
por: Aoh, Yu, et al.
Publicado: (2019)

Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia
por: Mohamed Ibrahim, Norlinah, et al.
Publicado: (2020)

The influence of initial symptoms on phenotypes in spinocerebellar ataxia type 3
por: Xu, Hao‐Ling, et al.
Publicado: (2019)

Spinocerebellar Ataxia Type 31 with Blepharospasm
por: Itaya, Sakiko, et al.
Publicado: (2018)

An understanding of spinocerebellar ataxia
por: Ramachandra, N.B., et al.
Publicado: (2015)

Parkinsonism in Spinocerebellar Ataxia
por: Park, Hyeyoung, et al.
Publicado: (2015)

Spinocerebellar ataxia: an update
por: Sullivan, Roisin, et al.
Publicado: (2018)

Abnormal eye movements in spinocerebellar ataxia type 3
por: Lin, Junyu, et al.
Publicado: (2021)

Supratentorial and Infratentorial Lesions in Spinocerebellar Ataxia Type 3
por: Wang, Po-Shan, et al.
Publicado: (2020)

Spinocerebellar ataxia type 3 with dopamine-responsive dystonia: A case report
por: Zhang, Xiao-Le, et al.
Publicado: (2021)

Axonal inclusions in spinocerebellar ataxia type 3
por: Seidel, Kay, et al.
Publicado: (2010)

Spinocerebellar ataxia type 10 in Chinese Han
por: Wang, Kang, et al.
Publicado: (2015)

Writer's cramp in spinocerebellar ataxia Type 1
por: Khwaja, Geeta Anjum, et al.
Publicado: (2016)

Cognitive impairment in Spinocerebellar ataxia type 10
por: Moro, Adriana, et al.
Publicado: (2016)

The Multiple Faces of Spinocerebellar Ataxia type 2
por: Antenora, Antonella, et al.
Publicado: (2017)

The Molecular Basis of Spinocerebellar Ataxia Type 7
por: Goswami, Rituparna, et al.
Publicado: (2022)

Spinocerebellar ataxia type 31 (SCA31)
por: Ishikawa, Kinya
Publicado: (2022)

Therapeutic Strategies for Spinocerebellar Ataxia Type 1
por: Kerkhof, Laurie M. C., et al.
Publicado: (2023)

Collaborative Efforts for Spinocerebellar Ataxia Research in the United States: CRC-SCA and READISCA
por: Lin, Chih-Chun, et al.
Publicado: (2020)

Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine
por: Chang, Jui-Chih, et al.
Publicado: (2021)

Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias
por: Gan, Shi-Rui, et al.
Publicado: (2017)

Multimodal evoked potentials in spinocerebellar ataxia types 1, 2, and 3
por: Chandran, Vijay, et al.
Publicado: (2014)

Diffusion Tensor Magnetic Resonance Imaging for Differentiating Multiple System Atrophy Cerebellar Type and Spinocerebellar Ataxia Type 3
por: Jao, Chi-Wen, et al.
Publicado: (2019)

Cell biology of spinocerebellar ataxia
por: Orr, Harry T.
Publicado: (2012)

Cognitive dysfunction in spinocerebellar ataxias
por: Teive, Helio Afonso Ghizoni, et al.
Publicado: (2009)

Neuroradiological Findings in the Spinocerebellar Ataxias
por: Meira, Alex Tiburtino, et al.
Publicado: (2019)

Clinical features and genetic characteristics of homozygous spinocerebellar ataxia type 3
por: Li, Quan-Fu, et al.
Publicado: (2020)

Impaired Cerebellum to Primary Motor Cortex Associative Plasticity in Parkinson’s Disease and Spinocerebellar Ataxia Type 3
por: Lu, Ming-Kuei, et al.
Publicado: (2017)

Far-infrared radiation protects viability in a cell model of Spinocerebellar Ataxia by preventing polyQ protein accumulation and improving mitochondrial function
por: Chang, Jui-Chih, et al.
Publicado: (2016)

Spinocerebellar ataxia type 6 and episodic ataxia type 2 in a Korean family.
por: Koh, S. H., et al.
Publicado: (2001)

Aqueous Extract of Paeonia lactiflora and Paeoniflorin as Aggregation Reducers Targeting Chaperones in Cell Models of Spinocerebellar Ataxia 3
por: Chang, Kuo-Hsuan, et al.
Publicado: (2013)

Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population
por: Chen, Szu‐Ju, et al.
Publicado: (2019)

Ataxic Severity Is Positively Correlated With Fatigue in Spinocerebellar Ataxia Type 3 Patients
por: Yang, Jin-Shan, et al.
Publicado: (2020)

Quantitative assessment of postural instability in spinocerebellar ataxia type 3 patients
por: Liu, Xia‐Hua, et al.
Publicado: (2020)

RNA Gain-of-Function in Spinocerebellar Ataxia Type 8
por: Daughters, Randy S., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qio8u3f2b6ma28vtd43puvtbl0